Pyridine derivatives inhibiting angiogenesis and/or VEGF...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S307000, C514S352000, C546S125000, C546S148000, C546S304000

Reexamination Certificate

active

07323474

ABSTRACT:
The invention relates to pyridine derivatives of formula (I)wherein the substituents and symbols are defined as indicated in the description, processes for the preparation thereof, their usage in the preparation of a pharmaceutical composition for the treatment of a disease which responds to an inhibition of angiogenesis, and pharmaceutical compositions containing such compounds.

REFERENCES:
patent: 3847919 (1974-11-01), Knowles et al.
patent: 4405790 (1983-09-01), McGill et al.
patent: 5654307 (1997-08-01), James et al.
patent: 6706731 (2004-03-01), Bold et al.
patent: WO 97/34876 (1997-09-01), None
patent: WO 98/13350 (1998-04-01), None
patent: WO 98/13354 (1998-04-01), None
patent: WO 98/35958 (1998-08-01), None
Kowalski, Journal of Heterocyclic Chemistry, vol. 31, No. 1, pp. 245-247, Jan.-Feb. 1994.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Pyridine derivatives inhibiting angiogenesis and/or VEGF... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pyridine derivatives inhibiting angiogenesis and/or VEGF..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyridine derivatives inhibiting angiogenesis and/or VEGF... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2770098

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.